论文部分内容阅读
[目的]观察还原型谷胱甘肽联合丹参注射液治疗非酒精性脂肪性肝病(NAFLD)的临床疗效。[方法]64例NAFLD随机分为治疗组32例,用还原型谷胱甘肽注射液1.2 g联合丹参注射液30 ml分别加入0.9%氯化钠250 ml中静脉滴注;对照组32例,用甘草酸二胺注射液150 mg加入0.9%氯化钠250 ml中静脉滴注,4周为1个疗程,观察治疗前后脂肪肝有关各项指标的变化。[结果]治疗组患者总有效率为90.6%,与对照组的65.6%比较,差异有统计学意义(P<0.05)。[结论]还原型谷胱甘肽联合丹参注射液对NAFLD疗效显著。
[Objective] To observe the clinical efficacy of reduced glutathione combined with Danshen injection in the treatment of non-alcoholic fatty liver disease (NAFLD). [Method] 64 cases of NAFLD were randomly divided into treatment group (n = 32), treated with 1.2 g of reduced glutathione injection and 30 ml of Salviae miltiorrhiza injection respectively. The control group (n = 32) With glycyrrhizic acid diamine injection 150 mg 0.9% sodium chloride 250 ml intravenous infusion, 4 weeks for a course of treatment before and after treatment to observe the changes of fatty liver indicators. [Results] The total effective rate in the treatment group was 90.6%, which was significantly different from that in the control group (65.6%) (P <0.05). [Conclusion] Reduced glutathione combined with Danshen injection has significant effect on NAFLD.